Recon Onkos Surgical® Successfully Completes Groundbreaking, First-in-Human Cases Using NanoCept™ Antibacterial Technology byTim AllenJanuary 9, 2025
Biologics Regulatory MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants byJosh SandbergJune 20, 2024
Recon Regulatory Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants byJosh SandbergApril 8, 2024
Top Stories Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center byJosh SandbergJuly 20, 2023
Recon Regulatory Top Stories Onkos Surgical Receives FDA 510(k) Clearance for 3D Printed, Patient-Specific Pelvic Reconstruction System byJosh SandbergJuly 14, 2022
Extremities Financial Top Stories Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis byJosh SandbergJune 14, 2022
Extremities Regulatory Top Stories Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery byJosh SandbergJune 22, 2021
Hospitals Regulatory 3D Systems’ VSP Orthopaedics Receives FDA 510(k) Clearance — Opening the Door to Personalized Treatment of Complex Musculoskeletal Disease byChris StewartSeptember 26, 2019
Biologics Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology byJosh SandbergAugust 28, 2019
Extremities Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions byJosh SandbergMarch 8, 2018
